ID

13610

Description

Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00615784

Lien

https://clinicaltrials.gov/show/NCT00615784

Mots-clés

Versions (1)
  1. 19/02/2016 19/02/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

19 février 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Myeloid Leukemia NCT00615784

Anglais

Eligibility Acute Myeloid Leukemia NCT00615784

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >= 18 years
Description

age >= 18 years

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
confirmed diagnosis of aml as proven by bone marrow biopsy
Description

confirmed diagnosis of aml as proven by bone marrow biopsy

Type de données

boolean

Alias
UMLS CUI [1]
C0023467
must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy
Description

must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0876099
ecog performance status of 0-2
Description

ecog performance status of 0-2

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
recovered from toxicities of prior chemotherapy
Description

recovered from toxicities of prior chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C2004454
UMLS CUI [1,2]
C0013221
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of pancreatitis
Description

history of pancreatitis

Type de données

boolean

Alias
UMLS CUI [1]
C0030305
active alcohol abuse
Description

active alcohol abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
taken bexarotene in the past
Description

taken bexarotene in the past

Type de données

boolean

Alias
UMLS CUI [1]
C0765273
wbc > 10,000/ul at time of enrollment
Description

wbc > 10,000/ul at time of enrollment

Type de données

boolean

Alias
UMLS CUI [1]
C0023508
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
Description

cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg

Type de données

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0591617
UMLS CUI [3]
C0010711
UMLS CUI [4]
C0876099
significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation
Description

significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5]
C0199470
UMLS CUI [6,1]
C0005823
UMLS CUI [6,2]
C0013227
active participant in any other investigational treatment study for aml
Description

active participant in any other investigational treatment study for aml

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
life expectancy of less than 1 month
Description

life expectancy of less than 1 month

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation
Description

use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation

Type de données

boolean

Alias
UMLS CUI [1]
C0079459
UMLS CUI [2]
C0079460
UMLS CUI [3]
C1134440
UMLS CUI [4]
C0014822
UMLS CUI [5]
C0537668
uncontrolled hyperlipidemia
Description

uncontrolled hyperlipidemia

Type de données

boolean

Alias
UMLS CUI [1]
C0020473
known history of hiv
Description

known history of hiv

Type de données

boolean

Alias
UMLS CUI [1]
C0019682
known active cns involvement with aml
Description

known active cns involvement with aml

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449389
UMLS CUI [1,2]
C0023467
women of childbearing potential or active breast feeding
Description

women of childbearing potential or active breast feeding

Type de données

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0006147
Retour au début de la page

Similar models

Eligibility Acute Myeloid Leukemia NCT00615784

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age >= 18 years
boolean
C0001779 (UMLS CUI [1])
aml
Item
confirmed diagnosis of aml as proven by bone marrow biopsy
boolean
C0023467 (UMLS CUI [1])
chemotherapy
Item
must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy
boolean
C0392920 (UMLS CUI [1])
C0876099 (UMLS CUI [2])
ecog
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
recovery from toxicity
Item
recovered from toxicities of prior chemotherapy
boolean
C2004454 (UMLS CUI [1,1])
C0013221 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
alcohol abuse
Item
active alcohol abuse
boolean
C0038586 (UMLS CUI [1])
bexarotene
Item
taken bexarotene in the past
boolean
C0765273 (UMLS CUI [1])
wbc
Item
wbc > 10,000/ul at time of enrollment
boolean
C0023508 (UMLS CUI [1])
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
Item
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
boolean
C0677881 (UMLS CUI [1])
C0591617 (UMLS CUI [2])
C0010711 (UMLS CUI [3])
C0876099 (UMLS CUI [4])
organ disfunction
Item
significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0199470 (UMLS CUI [5])
C0005823 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
participation status
Item
active participant in any other investigational treatment study for aml
boolean
C2348568 (UMLS CUI [1])
life expectancy
Item
life expectancy of less than 1 month
boolean
C0023671 (UMLS CUI [1])
g-csf, gm-csf, aranesp, erythropoietin, or neumega
Item
use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation
boolean
C0079459 (UMLS CUI [1])
C0079460 (UMLS CUI [2])
C1134440 (UMLS CUI [3])
C0014822 (UMLS CUI [4])
C0537668 (UMLS CUI [5])
hyperlipidemia
Item
uncontrolled hyperlipidemia
boolean
C0020473 (UMLS CUI [1])
hiv
Item
known history of hiv
boolean
C0019682 (UMLS CUI [1])
cns involvement
Item
known active cns involvement with aml
boolean
C0449389 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
childbearing potential or active breast feeding
Item
women of childbearing potential or active breast feeding
boolean
C3831118 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial